Today’s guest post comes from Peter Darch, SVP of Strategy and Operations at PHIL Inc.
Peter explains that growing pressure on drug pricing is exposing structural inefficiencies in gross-to-net (GTN) across traditional distribution channels. He argues that single-channel ecosystems can better coordinate affordability, coverage, and dispensing, improving both patient outcomes and brand performance.
Click here to learn more about PHIL’s technology solution for brands.
Read on for Peter’s insights.
Read more »
